Phase IIA Study in Patients With Schizophrenia

Completed · Phase 2 · Has a placebo group

Conditions studied: Schizophrenia

In brief

This study is designed to assess the effects of AZD 2624 in patients with schizophrenia

Key facts

Study ID

NCT00686998

Run by

AstraZeneca

People needed

106

Starts

2008-05-01

Expected to finish

2009-03-01

Last updated by the study team

2013-03-29

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Females of non-childbearing potential
• Diagnosis of Schizophrenia

You may not qualify if…

• Clinically relevant disease and /or abnormalities.
• Alcohol or substance abuse not in remission
• Enrollment in another investigational study within 30 days

Where it is running

• Research Site — Rockville, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.